[HTML][HTML] Impact of colorectal cancer screening on cancer-specific mortality in Europe: a systematic review
A Gini, EEL Jansen, N Zielonke, RGS Meester… - European Journal of …, 2020 - Elsevier
Background Populations differ with respect to their cancer risk and screening preferences,
which may influence the performance of colorectal cancer (CRC) screening programs. This …
which may influence the performance of colorectal cancer (CRC) screening programs. This …
Advances in fecal occult blood tests: the FIT revolution
GP Young, EL Symonds, JE Allison, SR Cole… - Digestive diseases and …, 2015 - Springer
There is a wide choice of fecal occult blood tests (FOBTs) for colorectal cancer screening.
Goal: To highlight the issues applicable when choosing a FOBT, in particular which FOBT is …
Goal: To highlight the issues applicable when choosing a FOBT, in particular which FOBT is …
The IARC perspective on colorectal cancer screening
B Lauby-Secretan, N Vilahur, F Bianchini… - … England Journal of …, 2018 - Mass Medical Soc
IARC View on Colorectal Screening The International Agency for Research on Cancer
concluded that screening for colorectal cancer with stool-based tests and with lower …
concluded that screening for colorectal cancer with stool-based tests and with lower …
Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test
M Zorzi, U Fedeli, E Schievano, E Bovo, S Guzzinati… - Gut, 2015 - gut.bmj.com
Objective Colorectal cancer (CRC) screening programmes based on the guaiac faecal
occult blood test (gFOBT) reduce CRC-specific mortality. Several studies have shown higher …
occult blood test (gFOBT) reduce CRC-specific mortality. Several studies have shown higher …
Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study
Objective To estimate benefits and harms of different colorectal cancer screening strategies,
stratified by (baseline) 15-year colorectal cancer risk. Design Microsimulation modelling …
stratified by (baseline) 15-year colorectal cancer risk. Design Microsimulation modelling …
[HTML][HTML] Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test …
JE Allison, CG Fraser, SP Halloran, GP Young - Gut and liver, 2014 - ncbi.nlm.nih.gov
Fecal immunochemical tests for hemoglobin (FIT) are changing the manner in which
colorectal cancer (CRC) is screened. Although these tests are being performed worldwide …
colorectal cancer (CRC) is screened. Although these tests are being performed worldwide …
Impact of screening program on incidence of colorectal cancer: a cohort study in Italy
OBJECTIVES: Colorectal cancer (CRC) screening using the fecal occult blood test (FOBT)
has been shown to be effective in reducing cause-specific mortality. However, although it …
has been shown to be effective in reducing cause-specific mortality. However, although it …
Colorectal cancer screening: tests, strategies, and perspectives
F Stracci, M Zorzi, G Grazzini - Frontiers in public health, 2014 - frontiersin.org
Screening has a central role in colorectal cancer (CRC) control. Different screening tests are
effective in reducing CRC-specific mortality. Influence on cancer incidence depends on test …
effective in reducing CRC-specific mortality. Influence on cancer incidence depends on test …
Split-dose preparation for colonoscopy increases adenoma detection rate: a randomised controlled trial in an organised screening programme
Objective Although a split regimen of bowel preparation has been associated with higher
levels of bowel cleansing, it is still uncertain whether it has a favourable effect on the …
levels of bowel cleansing, it is still uncertain whether it has a favourable effect on the …
An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles
RS Bresalier, C Senore, GP Young, J Allison… - Gut, 2023 - gut.bmj.com
Objective New screening tests for colorectal cancer (CRC) are rapidly emerging. Conducting
trials with mortality reduction as the end point supporting their adoption is challenging. We re …
trials with mortality reduction as the end point supporting their adoption is challenging. We re …